Ana Beloqui is an Assistant Professor and Research Associate from the Belgian Fund for Scientific Research (F.R.S.-FNRS) at the Université Catholique de Louvain (UCLouvain, Brussels, Belgium), and group leader in the Advanced Drug Delivery and Biomaterials lab at the Louvain Drug Research Institute from the UCLouvain. She holds a Bachelors in Pharmacy and a M.Sc. in Pharmacology, and she holds a PhD in Nanomedicine from the University of the Basque Country (Spain). Beloqui's main research interests are the investigation of the oral drug delivery route (especially focused on the oral delivery of peptides, proteins and antibodies) and the interaction of the drug delivery system with the gastrointestinal epithelium. This includes the study of the mechanisms of transport that drive the access of the drug delivery system into systemic circulation. Her research in mainly focused on the development of innovative oral drug delivery systems for the treatment of gastrointestinal diseases, mainly type 2 diabetes and inflammatory bowel diseases.